Trademark: 97573907
Word
INTELLIMMU
Status
Dead
Status Code
602
Status Date
Thursday, February 8, 2024
Serial Number
97573907
Mark Type
4000
Filing Date
Wednesday, August 31, 2022
Abandoned Date
Thursday, January 25, 2024

Trademark Owner History

Classifications
5 Diagnostic preparations for medical purposes; Depuratives for the body; Veterinary preparations for treatment of intestinal bacteria; Diagnostic preparations for medical or veterinary purposes; Pesticides; First aid kits; Dental abrasives; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the central nervous system; Medicines for alleviating constipation; Pharmaceutical preparations for treating diabetes; pharmaceutical preparations used for the treatment of reproductive system disorders; Aspirin; Medical preparations, namely, foot, hand and skin creams for diabetics; Medicines for human purposes, for treatment of hyperuricemia; Medical hemostatic paste; Medicines for human purposes, for the treatment of hepatitis B, Aids, retinal pigment degeneration and glioma; Medicines for human purposes, for the treatment of frequent micturition, urgency of urination and urge urinary incontinence; Pharmaceutical preparations for use in the treatment of muscle spasms, pain and related musculoskeletal disorders; Medicines for human purposes, for the treatment of gastric ulcer, duodenal ulcer and chronic gastritis; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical products for the treatment of cancer; Medicines for intestinal disorders; Pharmaceutical preparations for use in urology; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of eye diseases and conditions; all the aforementioned goods exclude dietary supplements
42 Technological research in the field of medicine; Research and development of new products for others; Product quality evaluation; Chemical analysis; Scientific research in the nature of conducting clinical trials for others; Scientific research and development; Consulting services in the field of pharmaceutical research and development; Scientific research for medical purposes in the area of cancerous diseases; Scientific investigations for medical purposes; Biotechnology research; Pharmaceutical drug development services; Biomedical research services; Research and development services in the field of antibodies; Pharmaceutical research services; Development of pharmaceutical preparations and medicines; Biological research; Medical research; Stem cell research services; all the aforementioned services are not in relation to dietary supplements

Trademark Events
Feb 8, 2024
Abandonment Notice E-Mailed - Failure To Respond
Feb 8, 2024
Abandonment - Failure To Respond Or Late Response
Feb 8, 2024
Assigned To Examiner
Oct 24, 2023
Notification Of Final Refusal Emailed
Oct 24, 2023
Final Refusal E-Mailed
Oct 24, 2023
Final Refusal Written
Aug 15, 2023
Teas/Email Correspondence Entered
Aug 14, 2023
Correspondence Received In Law Office
Aug 14, 2023
Teas Response To Office Action Received
Jun 26, 2023
Notification Of Non-Final Action E-Mailed
Jun 26, 2023
Non-Final Action E-Mailed
Jun 26, 2023
Non-Final Action Written
Jun 15, 2023
Assigned To Examiner
Sep 20, 2022
New Application Office Supplied Data Entered
Sep 3, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24